|
KMID : 1030220130140030138
|
|
Journal of Korean Diabetes
2013 Volume.14 No. 3 p.138 ~ p.143
|
|
|
Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis
|
|
Cho Eun-Hee
|
|
|
Abstract
|
|
|
|
Recently, dipeptidylpeptidase-4 (DPP-4) inhibitors have been widely used as a second-line therapy for type 2 diabetes because of their glucose-lowering efficacy, weight neutral effects and minimal hypoglycemia. However, there have been concerns regarding the lack of evidence of the long-term consequences of DPP-4 inhibitors on cardiovascular disease, acute pancreatitis and cancers; therefore, the effects of DPP-4 inhibitors on these three major diseases are reviewed in this article. A growing body of evidence demonstrates the cardioprotective role of DPP-4 inhibitors in animal and small clinical studies. However, clearly conflicting data regarding the effects of DPP-4 inhibitors on cancers and pancreatitis have been presented in preclinical and epidemiologic studies. The forthcoming long-term clinical studies on cardiovascular safety will provide more conclusive answers relating to the safety of DPP-4 inhibitors, including their effects on cancer and pancreatitis.
|
|
|
KEYWORD
|
|
|
Dipeptidyl-peptidase IV inhibitors, Cardiovascular diseases, Neoplasms, Pancreatitis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|